» Articles » PMID: 33997801

A Qualitative IgG ELISA for Detection of SARS-CoV-2-specific Antibodies in Syrian Hamster Serum Samples

Overview
Journal STAR Protoc
Publisher Cell Press
Date 2021 May 17
PMID 33997801
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

This protocol describes an indirect enzyme-linked immunosorbent assay for qualitative detection of IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Syrian hamster serum samples. We describe the preparation of inactivated virus antigens and the negative control antigen and the use of antigen-coated microtiter plates to detect SARS-CoV-2-specific antibodies from SARS-CoV-2-infected hamsters, including the criteria for differentiating positive versus negative reaction. The limited batch-to-batch variability of this assay has been verified with two batches of independently prepared antigens. For complete details on the use and execution of this protocol, please refer to Mohandas et al. (2021).

Citing Articles

A Novel Probiotic-Based Oral Vaccine against SARS-CoV-2 Omicron Variant B.1.1.529.

Chau E, Kwong T, Pang C, Chan L, Chan A, Yao X Int J Mol Sci. 2023; 24(18).

PMID: 37762235 PMC: 10530581. DOI: 10.3390/ijms241813931.


Inactivated SARS-CoV-2 vaccine candidate immunization on non-human primate animal model: B-cell and T-cell responses immune evaluation.

Ala R, Wijaya A, Susilowati H, Kuncorojakti S, Diyantoro , Rahmahani J Heliyon. 2023; 9(7):e18039.

PMID: 37519714 PMC: 10372371. DOI: 10.1016/j.heliyon.2023.e18039.


Monkeypox: An emerging zoonotic pathogen.

Beig M, Mohammadi M, Nafe Monfared F, Nasereslami S World J Virol. 2022; 11(6):426-434.

PMID: 36483104 PMC: 9724206. DOI: 10.5501/wjv.v11.i6.426.


Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model.

Yadav P, Mohandas S, Shete A, Sapkal G, Deshpande G, Kumar A iScience. 2022; 25(10):105178.

PMID: 36164480 PMC: 9493142. DOI: 10.1016/j.isci.2022.105178.


BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and .

Soto J, Diaz F, Retamal-Diaz A, Galvez N, Melo-Gonzalez F, Pina-Iturbe A Vaccines (Basel). 2022; 10(5).

PMID: 35632475 PMC: 9143576. DOI: 10.3390/vaccines10050721.


References
1.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

2.
Sarkale P, Patil S, Yadav P, Nyayanit D, Sapkal G, Baradkar S . First isolation of SARS-CoV-2 from clinical samples in India. Indian J Med Res. 2020; 151(2 & 3):244-250. PMC: 7366528. DOI: 10.4103/ijmr.IJMR_1029_20. View

3.
Mohandas S, Yadav P, Shete-Aich A, Abraham P, Vadrevu K, Sapkal G . Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model. iScience. 2021; 24(2):102054. PMC: 7829205. DOI: 10.1016/j.isci.2021.102054. View